CTNNB1 and hepatocellular carcinoma: To study the effects of RNAi-mediated inhibition in β-catenin-mutated HCC, we utilized a novel siRNA that targets the CTNNB1 gene, with both mouse and human specificity, encapsulated in a lipid nanoparticle (referred hereafter as LNP-CTNNB1).